Journal
IMMUNOBIOLOGY
Volume 222, Issue 1, Pages 45-54Publisher
ELSEVIER GMBH
DOI: 10.1016/j.imbio.2015.11.008
Keywords
Complement-dependent cytotoxicity; Opsonisation; Complement regulatory proteins; Cancer; C5a; C3a
Categories
Funding
- FRONTIER Excellence Initiative of the University of Heidelberg
- Stiftung fur Krebs- and Scharlachforschung Mannheim
Ask authors/readers for more resources
Constituting a part of the innate immune system, the complement system consists of over 50 proteins either acting as part of a 3-branch activation cascade, a well-differentiated regulatory system in fluid phase or on each tissue, or as receptors translating the activation signal to multiple cellular effector functions. Complement serves as first line of defence against infections from bacteria, viruses and parasites by orchestrating the immune response through opsonisation, recruitment of immune cells to the site of infection and direct cell lysis. Complement is generally recognised as a protective mechanism against the formation of tumours in humans, but is often limited by various resistance mechanisms interfering with its cytotoxic action, now considered as a great barrier of successful antibody-based immunotherapy. However, recent studies also indicate a pro-tumourigenic potential of complement in certain cancers and under certain conditions. In this review, we present recent findings on the possible dual role of complement in destroying cancer, especially if resistance mechanisms are blocked, but also under certain inflammatory conditions-promoting tumour development. (C) 2015 Elsevier GmbH. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available